CLINICAL_TRIALS ClinicalTrials.gov record with results posted

An Open-Label Phase 2 Study of Abaloparatide to Mitigate Distal Femoral Bone Loss Following Total Knee Arthroplasty

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04167163
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-06T00:00:44.604107+00:00
Published At: 2026-06-05T00:00:00+00:00
Record Updated At: 2026-06-05
Results Posted At: 2026-06-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Osteoporosis", "Arthroplasties, Knee Replacement"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-05"
protocolSection.identificationModule.nctId: "NCT04167163"
protocolSection.identificationModule.officialTitle: "An Open-Label Phase 2 Study of Abaloparatide to Mitigate Distal Femoral Bone Loss Following Total Knee Arthroplasty"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-06-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.